Cardiac gene expression of atrial natriuretic peptide (ANP) and that of brain natriuretic peptide (BNP) are markedly elevated after myocardial infarction. The cellular distribution and temporal responses of ANP and BNP messenger RNA (mRNA) expression were compared by in situ hybridization for 5 weeks after left coronary artery ligation in sheep. Ligation resulted in highly reproducible, transmural, left ventricular infarcts. Within the infarct, ANP mRNA appeared from 7 days after ligation, whereas BNP expression was undetectable in the infarct at any time. The cells synthesizing ANP were shown by in situ hybridization and immunocytochemistry to be fibroblasts invading the infarct. The appearance of ANP expression coincided with the transition of these cells to the myofibroblast phenotype. Treatment of cultured cardiac fibroblasts with transforming growth factor-␤ (10 ng/ml) induced the expression of ␣-smooth muscle actin, characteristic of the transformation to myofibroblasts, and raised ANP concentrations in the medium. In the surviving myocardium of the left ventricle, ANP and BNP expression increased in response to ligation, BNP mRNA was particularly strong at the lateral margins of the infarct. In both left and right atria, levels of BNP mRNA increased markedly over the first 18 h, whereas levels of atrial ANP mRNA decreased over 3 days after infarction. This is the first report of ANP expression and synthesis by cardiac fibroblasts invading the fibrotic scar, suggesting that ANP may be involved in regulating fibroblast proliferation during reparative fibrosis. (Endocrinology 141: 4690 -4697, 2000) T HE NATRIURETIC peptide family of hormones contributes to the control of body fluid homeostasis and blood pressure regulation through their combined actions on vasculature, kidneys, and adrenal glands (1). The three bestknown members of this family are atrial natriuretic peptide (ANP) (2), brain natriuretic peptide (BNP) (3), and C-type natriuretic peptide (CNP) (4). ANP and BNP are produced predominantly by the cardiac atrium and ventricle, respectively, in response to increased atrial and ventricular transmural pressure. These two natriuretic peptides have pronounced hypotensive, diuretic, and natriuretic effects (1).
T HE NATRIURETIC peptide family of hormones contributes to the control of body fluid homeostasis and blood pressure regulation through their combined actions on vasculature, kidneys, and adrenal glands (1) . The three bestknown members of this family are atrial natriuretic peptide (ANP) (2), brain natriuretic peptide (BNP) (3) , and C-type natriuretic peptide (CNP) (4) . ANP and BNP are produced predominantly by the cardiac atrium and ventricle, respectively, in response to increased atrial and ventricular transmural pressure. These two natriuretic peptides have pronounced hypotensive, diuretic, and natriuretic effects (1) .
Plasma levels of ANP and BNP are markedly elevated in heart failure (5) and after myocardial infarction (MI) (6) , and are powerful predictors of ventricular dysfunction and mortality (7) . Moreover, within heart tissue, gene expression of both ANP and BNP is reportedly up-regulated in animal models of MI and heart failure (8 -11) and in human heart disease (12, 13) . Although ANP is expressed primarily in the atria in adults, the ventricle is the major site of both ANP and BNP expression in embryos (14) . The appearance of increased ANP expression in adult ventricles is a marker for induction of the embryonic gene program during the development of hypertrophy (15) .
Most previous studies of natriuretic peptide expression in cardiac tissues have used Northern blotting or ribonuclease protection assays, and information about the cellular localization of natriuretic peptide expression during the response to myocardial infarction is sparse. To understand the molecular mechanisms involved in the response to cardiac ischemia, it is necessary to determine which cell type expresses the gene of interest. The cellular response to cardiac injury is initiated by an invasion of inflammatory cells, followed by infiltration by endothelial cells and fibroblasts to form granulation tissue. A complex interplay of paracrine factors released by macrophages and injured myocytes triggers the phenotypic switch of fibroblasts to myofibroblasts (16) , which deposit collagen to form the fibrotic scar. Changes at the site of injury are accompanied by ongoing hypertrophy and remodeling of the noninfarcted myocardium. The present study compares the cellular distribution of ANP and BNP expression at several time points corresponding to these stages of healing in infarcted and noninfarcted myocardium up to 5 weeks after left coronary artery ligation in sheep.
the corresponding regions of three sheep that had not undergone surgery to provide control data.
General anesthesia was induced by thiopentone (17 mg/kg, iv) and was maintained with halothane and nitrous oxide, with continuous monitoring of electrocardiography and arterial pressure. Left lateral thoracotomy and ligation of the coronary artery were performed as described previously (17, 18) . Postoperative analgesia was provided by 50 mg pethidine, im. This study was approved by the animal ethics committee of the Christchurch School of Medicine.
In situ hybridization, immunohistochemistry, and histology
After an overdose of sodium pentobarbitone (150 mg/kg), the heart was excised, and the dimensions (square centimeters) of the infarct were assessed by spreading the infarcted tissue flat over a centimeter grid. Tissue samples were rapidly collected and fixed in 4% paraformaldehyde with 0.1 m borate buffer (pH 9.5). In situ hybridization was performed on 20-m cryostat sections, as described previously (19) . The ovine ANP and BNP RNA probes were generated by in vitro transcription from DNA templates bearing 5Ј-and 3Ј-extensions encoding T7 and T3 RNA polymerase promoter sequences. The ovine ANP complementary DNA template, a 296-bp fragment of exon 2, was generated by PCR from sheep genomic DNA using primers based on the published ovine sequence (20) (ANP reverse primer, 5Ј-TTTGGAGGACAAGATGCCT; forward primer, 5Ј-CCCAATC-CACTCTGGGCT). The ovine BNP complementary DNA template, a 240-bp fragment of exon 2, was also generated by PCR from sheep genomic DNA (BNP reverse primer, 5Ј-AGCTGTTGGACCGTCTACGA; forward primer, 5Ј-TTGCAGCCCAGGCCACTGA). Adjacent sections were hybridized with ANP, BNP, and their respective control sense probes and exposed to x-ray film for 48 h. Sections were dipped in NTB-2 nuclear track emulsion (Eastman Kodak Co., Rochester, NY) for 14 days, developed, and counterstained with hematoxylin and eosin.
Immunohistochemistry for the detection of ANP immunoreactivity (ANP-IR) was performed on paraffin-embedded tissues using a peroxidase-labeled streptavidin-biotin kit (DAKO Corp., Carpinteria, CA). The antiserum against ovine ANP (21) was used at a final dilution of 1:500. Control sections were processed identically, except that the ANP antiserum was preabsorbed with 0.1 mg/ml human ␣ANP (Peninsula Laboratories, Inc., Belmont, CA). Additional controls were performed in which the ANP antibody was omitted to check for endogenous tissue peroxidase. Adjacent infarct sections were also stained for collagen using Masson Trichrome and were immunostained for factor VIII (to identify endothelial cells), ␣-smooth muscle actin (␣SMA) and vimentin (to identify myofibroblasts), using peroxidase-labeled streptavidin-biotin kits (DAKO Corp.).
Culture of ovine cardiac fibroblasts
Ovine cardiac fibroblasts were grown in primary culture following the method of Hafizi et al. (22) . Briefly, tissue blocks were excised from the infarct and periinfarct region of sheep heart 1 week after left coronary artery ligation and placed into HBSS with 20 mmol/liter HEPES at 4 C. The tissue was minced in HBSS using two sterile scalpels, transferred to HBSS with 1000 U/ml collagenase II (270 U/mg; Life Technologies, Inc., Gaithersburg, MD), and placed in a shaking water bath (37 C) for 2 h. To ensure cell dispersion, the mix was passed through a 50-ml syringe several times and reincubated for an additional hour. The cells were washed with fibroblast growth medium, consisting of DMEM (Life Technologies, Inc.) supplemented with 2 mmol/liter l-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 10% FCS (Life Technologies, Inc.); centrifuged (5 min at 1200 rpm); resuspended in fibroblast growth medium, and plated onto 10-cm plates. At 5 days the cells were trypsinized and replated onto six-well plates at equivalent density. Forty-eight hours later, the culture medium was replaced, and triplicate wells were treated with either 10 ng/ml transforming growth factor-␤ (TGF␤; R&D Systems, Minneapolis, MN) or control medium. To prevent endopeptidase degradation of ANP, phosphoramidon (2 ϫ 10 Ϫ5 m; Sigma, St Louis, MO) was added to all wells. After a further 48 h, the medium was removed for ANP assay (21). The cell density was calculated by counting nuclei in 10 individual microscope fields. Additional cultures were grown under identical conditions in microscope slide chambers and immunostained for ␣SMA, as described above.
Densitometry and statistics
The intensities of the ANP and BNP signals were quantified by measuring the densities of the x-ray autoradiographs. Imaging and data capture were performed on a Gel Doc 2000 (Bio-Rad Laboratories, Inc., Richmond, CA), and the densities were assessed within a representative area, using the Quantity One software package. Nonparametric statistical analyses were performed on the density data. Kruskall-Wallis analysis was used to compare the grouped data for each cardiac region to determine whether a significant response to myocardial infarction was obtained, and the Mann-Whitney U test was applied to determine at which time points the response was significantly different from control. Concentrations of ANP in the cell culture experiments were analyzed by ANOVA. Significance was taken at the P Ͻ 0.05 level.
Results
A separate report describes the hemodynamic and neurohumoral responses to myocardial infarction in the seven sheep studied for 5 weeks after coronary artery ligation (17) . Left coronary artery ligation resulted in highly reproducible, transmural, left ventricular anteroapical infarcts, which displayed significant wall thinning (average infarct area, 33 cm 2 ). The ligated sheep had significant increases in plasma levels of creatine kinase and troponin T, correlating positively with the degree of cardiac injury. The sheep exhibited chronic reductions in left ventricular ejection fraction, cardiac output, and mean arterial pressure and increased left and right atrial pressure and pulmonary arterial pressure compared with noninfarcted, sham-operated sheep. These changes were associated with rapid and sustained increases in plasma ANP and BNP concentrations (17) .
Expression within the infarct and periinfarct regions
Gene expression of ANP and BNP in samples collected from the region of the infarct (thin-walled area with no surviving myocardium) and from the periinfarct area (transition between ischemic tissue and viable myocardium) are shown in Fig. 1 . Natriuretic peptide expression in tissues from control sheep and sham-operated sheep were comparable, and only tissues from the control sheep are illustrated. The apex of the left ventricle of control sheep displayed very low levels of ANP and BNP messenger RNA (mRNA), with scattered foci of positive cells. At 18 h and 3 days after ligation, the infarcted region consisted entirely of enuclated myocytes, and no expression of either ANP or BNP within infarcted tissue was detected. However, at 7 days, when degradation of the necrotic myocardium and infiltration by fibroblasts were observed, ANP mRNA became apparent on both epicardial and endocardial aspects of the infarct, but was more marked on the endocardial side. Expression of ANP in the infarct was still pronounced at 3 weeks after ligation, but was barely detectable at 5 weeks. In contrast, BNP expression was not detectable in the infarct at any time. Both ANP and BNP sense probes were run in parallel in all experiments and gave similarly low levels of background hybridization. In the interests of space only the BNP sense autoradiographs are illustrated in Figs. 1 and 4 . Periinfarct samples were collected from the lateral margins of the infarct (Fig. 1) , which included zones of dead myocardium that lacked expression of either natriuretic peptide and zones of viable myocardium exhibiting intense expression of both ANP and BNP. The intensity of BNP expression was particularly strong in these periinfarct regions at 18 h and 3 days after ligation; this was the only site of sampling in which BNP expression exceeded that of ANP.
Expression of ANP by infarcted tissue was localized to fibroblasts invading the infarct (Fig. 2, A and B) , indicated by the clustering of silver grains over the fibrotic scar. Identification of ANP-IR in fibroblasts was confirmed by staining with Masson Trichrome, which detects collagen deposition, characteristic of fibrosis (Fig. 2C) . Levels of background can be seen in control sections hybridized with an ANP sense probe (Fig. 2D) . The synthesis of ANP peptide by fibroblasts was established by immunocytochemistry (Fig. 2E) , which showed a cellular distribution of ANP-IR similar to that of ANP mRNA in 7-day, 3-week, and 5-week tissue sections. Control sections incubated with ANP antiserum preabsorbed with excess ANP or with primary antibody omitted showed no staining (Fig. 2F) . The ANP-IR was observed in bands of fibroblasts, especially in regions adjacent to the necrotic myocardium. In contrast, hybridization with a BNP probe showed no detectable signal within fibrotic tissue (Fig.  2G) . The cellular localization and timing of ANP staining at 7 days were coincident with the appearance of ␣SMA (Fig.  2H) and vimentin (not shown), indicative of the phenotypic switch of fibroblasts to myofibroblasts. The distribution of ANP staining was distinct from that of endothelial cells, identified by immunostaining for factor VIII, which stained endothelial cells lining blood vessels and in columns migrating into the scar (not shown).
Primary cultures of ovine cardiac fibroblasts proliferated to become more than 90% confluent 4 days after plating out, but did not show ␣SMA immunostaining. In contrast, cardiac fibroblasts treated with TGF␤ for 48 h stopped proliferating, so cell density was significantly lower (36 Ϯ 15 cell/field) sense probe (magnification, ϫ40). E, ANP-IR in fibroblasts indicated by brown cytoplasmic staining detected by peroxidase labeling (magnification, ϫ40). F, Adjacent control section with primary antibody omitted. Nuclei are stained purple with hematoxylin (magnification, ϫ40). G, Hybridization with BNP probe, under darkfield illumination (magnification ϫ40). H, Staining for myofibroblasts (brown) with ␣SMA antibody (magnification ϫ40). Scale bar, 25 m in all panels.
than that in control cells (436 Ϯ 88 cells/field; P Ͻ 0.001). Fibroblasts treated with TGF␤ stained intensely for ␣SMA microfilaments (not shown), characteristic of the transformation to myofibroblasts. The ANP concentrations in medium collected from the wells treated with TGF␤ (2.86 Ϯ 0.09 pmol/liter) were slightly, but significantly, greater than those in wells treated with either medium alone (2.23 Ϯ 0.09 pmol/liter; P ϭ 0.008) or medium from control cells (2.43 Ϯ 0.22 pmol/liter; P ϭ 0.05).
Expression in noninfarcted myocardium
Samples were taken from the left and right atria, mid left ventricle (1 cm from the edge of the infarct), remote left ventricle (above the point of attachment of the papillary In both left and right atria, levels of ANP expression decreased over the first 3 days after infarction; this decrease was significantly different from the control value at 3 days (Figs.  3 and 4) . In contrast, there was a significant increase in atrial BNP expression in the group data after ligation. The most marked increase in both left and right atrial BNP mRNA was over the first 18 h after ligation, showing an average 2-fold increase in response to ligation. Despite this marked activation of BNP mRNA in response to ligation, absolute levels of BNP expression in the atria remained less than those of ANP in both control and ligated sheep. Levels of ANP and BNP expression also increased significantly in samples of mid left ventricle (distinct from the infarcted region) and remote left ventricular myocardium over the first 3 days after ligation (Fig. 3) . Levels of BNP mRNA in mid left ventricle were significantly greater than control values at 18 h after ligation. Levels of ANP and BNP expression in right ventricle and interventricular septum tended to increase after ligation, but were not significantly different from control values after correcting for background.
Discussion
This study provides the first comparison of ANP and BNP expression in each cardiac chamber in response to myocardial infarction and reports the novel finding of expression and synthesis of ANP by cardiac fibroblasts infiltrating infarcted heart tissue.
Expression of ANP by cardiac fibroblasts has not previously been reported to our knowledge. However, a role for ANP in the proliferation of fibroblasts of cardiac origin has been suggested by a number of reports. First, cardiac fibroblasts express all three NP receptors (23) and can generate the second messenger cGMP in response to both ANP and CNP. Second, ANP inhibits the DNA synthesis and proliferation of cardiac fibroblasts in culture (24, 25), and ANP inhibits the synthesis of collagen by rat and human cardiac fibroblasts via cGMP (26). Previously, it has been assumed that any action of ANP on fibroblasts is paracrine, after production by adjacent myocardial cells. Transcription of the ANP gene in nonmyocyte cells is normally repressed through the binding of fibroblast nuclear extracts to an E box motif and adjacent sequences within the ANP promoter (27). It is feasible that the phenotypic switch of fibroblasts to myofibroblasts may allow induction of the ANP promoter in these cells.
In vivo, the appearance of myofibroblasts has been linked to a complex interplay of locally produced growth factors, including angiotensin II, endothelin-1 TGF␤, and plateletderived growth factor (16) . However, it has been reported that cultured skin fibroblasts can be induced to transform to myofibroblasts by treatment with TGF␤ alone (28). To determine whether cardiac fibroblasts could also be induced to transform to myofibroblasts in culture, cardiac fibroblasts were cultured from sheep heart 1 week after myocardial infarction in the current study. Cardiac fibroblasts treated with TGF␤ also displayed intense ␣SMA immunostaining and a decrease in cell density, indicating the phenotypic switch of these cells to myofibroblasts. Associated with TGF␤ treatment was a small, but significant, increase in ANP concentrations in the culture medium compared with those in control fibroblasts despite the fact that the cell density of TGF␤-treated cultures was 10-fold lower than that of control fibroblasts. These ANP levels are very low, and in vivo other growth factors may elicit a greater release of ANP. However, if ANP acts in an autocrine manner within the fibrotic region, small changes in ANP levels may be sufficient to activate receptors on adjacent cells.
There is now considerable in vitro data suggesting that ANP may have a role in regulating the proliferation of fibroblasts and the resultant deposition of collagen. A role for ANP in regulating the development of fibrosis in vivo is supported by the observation of cardiac fibrosis in knockout mice, which lack the gene for the natriuretic peptide receptor A (29). These mice have hypertension, which is lethal in males by 6 months of age, and exhibit both ventricular hypertrophy and fibrosis. This model suggests that ANP may play a major role in regulating ventricular remodeling secondary to compensatory hypertrophy and cardiac fibrosis. These studies lead us to suggest that ANP may be involved in an autocrine manner in regulating fibroblast proliferation during reparative fibrosis. At present, we do not know whether ANP is also expressed in reactive fibrosis in ventricles during mechanical overload. Chronic models of hypertrophy and fibrosis could clarify whether fibroblasts responsible for reactive fibrosis show ANP expression. One report describing a transgenic mouse model of hypertropic cardiomyopathy (30) observed numerous foci of ANP expression in the ventricles in regions associated with fibrosis and collagen accumulation.
Several neuroendocrine factors involved in cardiac fibroblast proliferation could be involved in triggering the expression of ANP in fibroblasts 7 days after infarction. Angiotensin II secreted from adjacent myocardium and macrophages is reported to induce hypertrophy and fibrosis by releasing TGF␤1 and endothelin-1 from fibroblasts (31) and stimulating the expression of the transcription factors Egr-1 and c-Fos in cultured cardiac fibroblasts (32). Both TGF␤1 and basic fibroblast growth factor, which are involved in the growth of cardiac fibroblasts and the switch to myofibroblasts during fibrosis (16) , have been demonstrated to stimulate ANP secretion from cultured neonatal cardiomyocytes (33). In this study, TGF␤1 alone elicited a rise in ANP levels in cardiac fibroblast cultures, but the role of basic fibroblast growth factor in ANP production by cardiac fibroblasts was not examined.
In contrast to ANP, we did not detect BNP expression in infarcted myocardium. Synthesis of BNP is regulated in part by modulating BNP message stability through downstream cisacting sites on the BNP mRNA (34). It is possible that BNP is transiently expressed in the fibrotic scar, but we failed to detect it. Like ANP, BNP and CNP also have been implicated in the regulation of fibroblast mitogenesis (24, 25). Levels of CNP expression in myocardial tissue are considered to be extremely low (35), and hence, expression of CNP was not examined in this study. However, CNP also strongly inhibits DNA synthesis in cultured cardiac fibroblasts (25), and the natriuretic peptide receptor B is expressed in fibroblasts (23). To date, there have been no reports of CNP synthesis by fibroblasts, but CNP may also participate in the regulation of fibroblast proliferation.
This study is the first to compare the concurrent changes in ANP and BNP expression at the cellular level in all cardiac chambers over several weeks following MI. Cardiac expression of ANP and BNP mRNA over 3 days after infarction has been compared in rats using Northern blotting (8, 11) . In those studies a rapid rise of BNP mRNA was observed in both atria and ventricles, as early as 4 h after coronary artery ligation (8) , and a later increase in ANP mRNA (3 days) was observed in ventricles. Although previous studies in rats have consistently observed increased ANP mRNA in ventricles after MI, atrial ANP mRNA has been reported to be decreased (36), unchanged (11, 37, 38) , or increased (39).
These previous studies are consistent with the present study of the response of ANP and BNP after infarction. We observed atrial ANP expression to decrease over the first 3 days after MI, whereas there was a rapid increase in atrial BNP expression within 18 h. The left ventricle showed marked increases in both ANP and BNP mRNA, especially at the margins of the infarct, which may be a response to both the regional mechanical stress as well as hemodynamic overload (40). The changes in mRNA observed in this study also correlate well to circulating levels of ANP and BNP in response to MI in sheep. After coronary artery ligation, the relative increase in plasma BNP in response to MI was greater than that in ANP (17) . Despite this, the absolute levels of plasma ANP exceeded BNP both at baseline and after MI, concordant with the relationship between cardiac expression of ANP and BNP reported here.
Previous studies of ANP or BNP synthesis at the cellular level after myocardial infarction have generally examined the infarcted ventricle only. Increased ANP-IR was seen at the lateral margins of the infarct in rat hearts after coronary artery ligation (8, 41) . Similarly, intense BNP-IR was observed in myocytes surrounding the infarct (8). Hama and co-workers observed no ANP-IR or BNP-IR in infiltrating cells or fibrous tissue sampled up to 3 days after MI. This finding is not at odds with the present study, in which ANP-IR in fibroblasts was not observed until 7 days after MI. One previous study examined ANP mRNA in the rat heart after coronary artery ligation (36) by in situ hybridization and observed ANP expression in the ventricular epicardium bordering the infarct area 1 week post-MI. The identity of the cells producing ANP was not established.
In conclusion, this study has documented the regional changes in ANP and BNP gene expression in heart tissue up to 5 weeks after coronary artery ligation in an ovine model of myocardial infarction. The results have established that BNP mRNA responds more rapidly and with a greater relative rise than ANP mRNA, particularly in the atria. Expression of both peptides was markedly increased in the left ventricle, especially at the margins of the infarct. The present study also describes ANP expression and synthesis by cardiac fibroblasts within the fibrotic scar, coinciding with the transition of these cells to myofibroblasts. This finding leads to the proposal that ANP is involved in an autocrine manner in regulation of fibroblast proliferation and possibly the phenotypic switch to myofibroblasts during reparative fibrosis.
